LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery

NCT07168421 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Perioperative Myocardial Injury
Autonomic Dysfunction
Cardiovascular (CV) Risk
Major Surgery
Beta Blocker
Myocardial Injury After Non-cardiac Surgery

Interventions

DRUG: Landiolol

Sponsor

Insel Gruppe AG, University Hospital Bern